OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy

In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.